MAYELANA NATHI
I-Shandong Xinhua Pharmaceutical Co., Ltd.isisekelo esikhulu kunazo zonke sokukhiqiza imishanguzo yokulwa nezidakamizwa kanye ne-analgesic emhlabeni jikelele, baqale ibhizinisi lamazwe omhlaba kusukela ngo-1992, abanolwazi lweminyaka engama-30 ebhizinisini lamazwe omhlaba. Kulezi zinsuku iShandong Xinhua isungule ubudlelwano obusondelene neBayer, Johnson & Johnson, GlaxoSmithKline, Pfizer kanye neminye imidondoshiya yezemithi eyahlukahlukene yamazwe omhlaba, umthamo wonyaka wokuthekelisa ukhuphukile usuka ku-2 million USD wokuqala waya ngaphezu kuka-350 million USD. I-Shandong Xinhua yinkampani ephezulu yokuthumela ama-API ephezulu kanye nenkampani ephezulu yokuthumela kwamanye amazwe imithamo / imikhiqizo eqediwe e-China. Yonke imikhiqizo isidlulile isitifiketi se-GMP, izakhiwo zidlulile ukuhlolwa kwesayithi yi-US FDA, UK MRHA ne-EU EDQM. I-Shandong Xinhua igxile embonini yezemithi cishe iminyaka engama-80, ngomugqa wokukhiqiza ohlanganisiwe osuka kubalamuli, ama-API nemithamo / imikhiqizo eqediwe. Ku-2018, indawo entsha eqediwe yemikhiqizo enamathebulethi angama-25 billion yasungulwa futhi yafakwa ekukhiqizeni, ngokuvunyelwa kokuhlolwa kwesiza sase-US FDA kanye nokwamukelwa kwe-UK MHRA GMP, kudlala indima ebaluleke kakhulu ekukhiqizeni inkontileka neBayer, iPfizer , Imikhiqizo enelebula iRoche, DSM, nePerrigo emakethe yase-US ne-EU.